RYHAX Mutual Fund

NAV$125.30
Showing 10 of 136 holdings(as of Mar 31, 2026)Top 10 Weight: 22.81%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company3.67%767$705.5K-Health CarePharmaceuticals
2JNJJOHNSON AND JOHNSON3.25%2,562$626.3K-124Health CarePharmaceuticals
3ABBVAbbvie Inc Health Care2.57%2,273$494.4KProProPro
4MRKMerck & Co. Inc.2.34%3,751$451.2KProProPro
5UNHUnited Health Group2.09%1,485$401.8KProProPro
6TMOThermo Fisher Scientific Inc1.87%732$359.8KProProPro
7AMGNAmgen Inc.1.82%995$350.1KProProPro
8ABTAbbott Laboratories1.74%3,259$334.6KProProPro
9PFEPfizer Inc USD 0.051.74%11,904$334.3KProProPro
10GILDGilead Sciences Inc1.72%2,379$331.6KProProPro
See the other 126 holdings of RYHAX
Every position with sector, industry and share changes, as reported Mar 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesImmunologyLife Sciences ToolsSemiconductorsAging PopulationHealth InsuranceManaged CareDigital HealthHealth & WellnessBiotechnology ToolsData & AnalyticsOncology

RYHAX Mutual Fund Top Holdings

RYHAX holdings top 10 positions. The top 10 holdings account for 22.8% of the fund, led by Eli Lilly And Company at 3.7%, JOHNSON AND JOHNSON at 3.3%, Abbvie Inc Health Care at 2.6%.

RYHAX portfolio concentration is well-diversified, with the top 10 representing 22.8% of total assets. The largest sector exposure is Health Care at 81.5%.

RYHAX sector allocation provides a detailed breakdown. RYHAX overlap tool shows how holdings compare to other funds in your portfolio.